News Clip2:00
Curated Video

Peru COVID-19: Healthcare workers strike, demanding better conditions

9th - Higher Ed
Doctors and health workers go on strike in Peru as the Latin American nation records the highest coronavirus death rate per capita in the world.
News Clip4:45
Curated Video

'Very positive': UK vaccine prompts immune response in

9th - Higher Ed
Early results indicate Oxford University's COVID-19 vaccine is safe and triggers immune response.
News Clip1:53
Curated Video

Vaccine trial results good news but there's a long way to go: WHO

9th - Higher Ed
Dr. Michael Ryan, executive director of the World Health Organization's emergencies program, is encouraged by the most recent coronavirus vaccine data and says large-scale, real world trials will come next.
News Clip5:06
Curated Video

Sam Rainsy interview on Cambodia's mass opposition trial

9th - Higher Ed
Mass trial on treason charges - Cambodian opposition members back in court accuse the government of political persecution.
News Clip6:00
Curated Video

Infectious disease specialist on China's early vaccine test and a possible influenza threat

9th - Higher Ed
'I really, really hope they're collecting detailed data,' Dr. Isaac Bogoch says of China's jump to try out a coronavirus vaccine on its soldiers. The vaccine is approved for human trials in Canada.
News Clip2:50
Curated Video

South Africa to start continent's first coronavirus vaccine pilot

9th - Higher Ed
African country with highest number of confirmed COVID-19 infections to begin trial of vaccine involving 2,000 people.
News Clip2:10
Curated Video

WHO gives update on vaccine development for COVID-19

9th - Higher Ed
The World Health Organization's chief scientist says AstraZeneca appears to be in the lead in the effort to develop a coronavirus vaccine, but Chinese companies are making significant strides.
News Clip6:15
Curated Video

Toronto respirologist explains excitement about drug dexamethasone for treating COVID-19 patients

9th - Higher Ed
'This drug seems to be effective in the sickest patients,' says Dr. Samir Gupta, but doctors are still waiting to see the details of the study.
News Clip3:31
Curated Video

Johnson & Johnson Developing COVID-19 Vaccine, Expects Approval By Early 2021

9th - Higher Ed
Johnson & Johnson's chief scientific officer, Dr. Paul Stoffels, talks rapid development of a COVID-19 vaccine and steps the company is taking to meet its 2021 deadline for an approved drug.
News Clip6:50
Curated Video

How well will COVID-19 vaccines work in the real world?

9th - Higher Ed
Infectious disease specialists answer questions about COVID-19 vaccines including if results from clinical trials will hold up in the real world.
News Clip0:14
Curated Video

Moderna Begins Coronavirus Vaccine Trials

9th - Higher Ed
Moderna announces the first rounds of its coronavirus vaccine have been given to patients. They will receive another round of treatment in 28 days and will be monitored for a year.
News Clip5:06
Curated Video

First Covid-19 vaccine trials set to get underway in Canada

9th - Higher Ed
Dalhousie University's Scott Halperin, director of the Canadian Center for Vaccinology, discusses the trials that will take place in Canada on a vaccine being developed by China's CanSino Biologic.
News Clip2:17
Curated Video

Moderna

9th - Higher Ed
Moderna early vaccine results promising.
News Clip7:18
Curated Video

Infectious disease specialist tackles key topics related to COVID-19

9th - Higher Ed
Dr. Isaac Bogoch says a small, new vaccine trial by a U.S. company has passed some preliminary hurdles, but notes 'it's very, very early' on the path to finding a safe vaccine.
News Clip6:25
Curated Video

Toronto respirologist explains significance of Health Canada's approval of antibody test for COVID-19

9th - Higher Ed
'In some ways I'd call it a game changer,' because it's one of the first steps in figuring out the level of immunity from the coronavirus, said Dr. Samir Gupta.
News Clip1:58
Curated Video

Vital Kamerhe, top aide to DRC president, on trial for corruption

9th - Higher Ed
President Felix Tshisekedi's chief of staff and two other defendants accused of embezzling more than $50m.
News Clip8:05
Curated Video

Asian countries want more scrutiny of Chinese COVID-19 vaccine

9th - Higher Ed
Some seek more proof it is safe and effective before they approve it, others are pushing forward with their roll-out.
News Clip8:00
Curated Video

Canadian vaccine candidate shows promising results

9th - Higher Ed
A University of Saskatchewan lab says its vaccine candidate has induced a strong immune response in ferrets. The lab is targeting human clinical trials in the fall. Power & Politics speaks to Dr. Volker Gerdts, director at VIDO-InterVac.
News Clip2:54
Curated Video

Senegal trials begin for $1 COVID-19 test kit

9th - Higher Ed
Trials have begun in Senegal on a coronavirus testing kit that gives results in 10 minutes.
News Clip2:00
Curated Video

Antiviral drug remdesivir shows promise as COVID-19 treatment

9th - Higher Ed
The antiviral drug remdesivir is showing promise as a COVID-19 treatment in early U.S. clinical trials, though other research hasn’t seen as much success.
News Clip2:40
Curated Video

COVID-19 vaccine trials starting in UK

9th - Higher Ed
Scientists at Oxford Jenner Institute began a trial involving 1,100 people last week, which they will expand to 6,000 in May.
News Clip2:06
Curated Video

World's first Syria torture trial opens in Germany

9th - Higher Ed
Two ex-military members accused of torture had been living in Germany as refugees and were arrested over a year ago.
News Clip8:44
Curated Video

China approves COVID-19 vaccine for military use

9th - Higher Ed
A vaccine developed by a Chinese company in collaboration with the Canadian government will skip a final phase of texting and will be used on Chinese soldiers. "I really, really hope they're collecting detailed data," says infectious...
News Clip8:43
Curated Video

COVID-19 vaccine shows positive results in first phase of human trials

9th - Higher Ed
Pharmaceutical company AstraZeneca and scientists at Oxford University in the U.K. are seeing early signs of success in the first human trial for a COVID-19 vaccine. Phase 1 of the trial had more than 1,000 participants between the ages...